AxoGen, Inc.
NASDAQ: AXGN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael D. Dale
- Employees
- 451
- Headquarters
- Alachua, United States
- IPO year
- 1986
- Market cap
- $2.3B
- Website
- https://www.axogeninc.com
Loading AXGN…
Loading profile data…Frequently asked questions about AXGN
What does AxoGen, Inc. (AXGN) do?
AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps...
Where does AXGN trade?
AxoGen, Inc. (AXGN) trades on the NASDAQ Capital Market.
What sector is AXGN in?
AxoGen, Inc. (AXGN) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of AxoGen, Inc.?
Michael D. Dale is the chief executive officer of AxoGen, Inc. (AXGN).
Where is AxoGen, Inc. headquartered?
AxoGen, Inc. is headquartered in United States.
Does AXGN pay a dividend?
AxoGen, Inc. (AXGN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AXGN go public?
AxoGen, Inc. (AXGN) completed its initial public offering in 1986.